New combo therapy aims to suppress hepatitis b virus in stubborn cases
Disease control
Recruiting now
This study tests a new drug called GST-HG141 (Neracorvir) in people with chronic hepatitis B who still have the virus despite taking standard antiviral pills. About 526 adults aged 18-70 will receive either the new drug or a placebo added to their current medication. The goal is …
Phase: PHASE3 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC